InvestSMART

Invex Therapeutics Ltd (ASX: IXC) - Announcements

- Current share price for IXC : $0.130

ASX company news and announcements for Invex Therapeutics Ltd (IXC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invex Therapeutics Ltd (IXC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invex Therapeutics Ltd (IXC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invex Therapeutics Ltd (IXC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$10 Quarterly Activities/Appendix 4C Cash Flow Report 24 Apr 2026 12:13PM $0.100 $0.130 risen by 30%
$10 Invex to Expand Preclinical Research Program 24 Apr 2026 8:11AM $0.100 $0.130 risen by 30%
$10 Resignation of Joint Company Secretary 23 Mar 2026 12:27PM $0.100 $0.130 risen by 30%
$10 Results of Meeting 17 Feb 2026 6:40PM $0.120 $0.130 risen by 8.33%
$10 Appendix 4D and Half Year Report 12 Feb 2026 1:34PM $0.120 $0.130 risen by 8.33%
$10 Quarterly Activities/Appendix 4C Cash Flow Report 22 Jan 2026 4:16PM $0.115 $0.130 risen by 13.04%
$10 Notice of Annual General Meeting/Proxy Form 16 Jan 2026 12:38PM $0.115 $0.130 risen by 13.04%
$10 Deferral of Annual General Meeting 20 Nov 2025 8:23PM $0.120 $0.130 risen by 8.33%
$10 Initial Director's Interest Notice x 2 10 Nov 2025 1:02PM $0.110 $0.130 risen by 18.18%
$10 Reinstatement to Quotation 10 Nov 2025 9:38AM $0.115 $0.130 risen by 13.04%
$10 Board and Officer Appointments and Company Address Change 10 Nov 2025 9:37AM $0.115 $0.130 risen by 13.04%
$10 Final Director's Interest Notice 7 Nov 2025 3:44PM $0.115 $0.130 risen by 13.04%
$10 Final Director's Interest Notice 7 Nov 2025 3:22PM $0.115 $0.130 risen by 13.04%
$10 Resignation of Directors, Co Sec and Cancellation of Meeting 7 Nov 2025 3:22PM $0.115 $0.130 risen by 13.04%
$10 Suspension from Official Quotation 7 Nov 2025 2:41PM $0.115 $0.130 risen by 13.04%
$10 Pause in Trading 7 Nov 2025 2:20PM $0.115 $0.130 risen by 13.04%
$10 Exenatide shows additional positive benefits in brain model 3 Nov 2025 2:11PM $0.115 $0.130 risen by 13.04%
$10 Notice of Annual General Meeting/Proxy Form 24 Oct 2025 3:07PM $0.130 $0.130 fallen by 0%
$10 Change in substantial holding 17 Oct 2025 4:02PM $0.140 $0.130 fallen by 7.14%
$10 Notice of General Meeting/Proxy Form 8 Oct 2025 3:34PM $0.135 $0.130 fallen by 3.70%
$10 Quarterly Activities/Appendix 4C Cash Flow Report 3 Oct 2025 9:16AM $0.150 $0.130 fallen by 13.33%
$10 Reinstatement to Quotation 30 Sep 2025 9:55AM $0.160 $0.130 fallen by 18.75%
$10 Response to ASX Price and Volume Query 30 Sep 2025 9:55AM $0.160 $0.130 fallen by 18.75%
$10 Corporate Update 30 Sep 2025 9:55AM $0.160 $0.130 fallen by 18.75%
$10 Director Nominations AGM 29 Sep 2025 12:09PM $0.160 $0.130 fallen by 18.75%

1 - 25 of 296 results

Page 1 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.